Some Speculations about Prions, Amyloid, and Alzheimer's Disease

New England Journal of Medicine

Volumn 310, Issue 10, 1984, Pages 661-663

  Prusiner, Stanley B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID;

ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM; CREUTZFELDT JAKOB DISEASE; ETIOLOGY; GERSTMANN SYNDROME; HUMAN; KURU; PRION;

EID: 0021344124     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198403083101021     Document Type: Editorial

References (21)

1. Gajdusek DC. Unconventional viruses and the origin and disappearance of kuru. Science 1977; 197: 943–60.
2. Masters CL, Gajdusek DC, Oibbs CJ Jr. Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Straüssler syndrome. Brain 1981; 104: 559–88.
3. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216: 136–44.
4. McKinley MP, Bolton DC, Prusiner SB. A protease-resistant protein is a structural component of the scrapie prion. Cell 1983; 35: 57–62.
5. Prusiner SB, McKinley MP, Bowman KA, et al. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 1983; 35: 349–58.
6. Prusiner SB, Boton DC, Groth DF, Bowman KA, Coehran SP, McKinley MP. Further purification and characterization of scrapie prions. Biochemistry 1982; 21: 6942–50.
7. Diringer H, Gelderblom H, Hilmert H, Özel M, Edelblulh C, Kimberlin R. Scrapie infectivity, fibrils and low molecular weight protein. Nature 1983; 306: 476–8.
8. Merz PA, Somerville RA, Wisniewski HM, Igbal K. Abnormal fibrils from scrapie infected brain. Acta Neurol Pathol (Berlin) 1981; 54: 63–74.
9. Glenner GG. Amyloid deposits and amyloidosis: the β-fibrilloses. N Engl J Med 1980; 302: 1283–92, 1333–43.
10. Beck E, Daniel FM. Kuru and Creutzfeldt-Jakob disease; neuropathological lesions and their significance. In: Prusiner SB, Hadlow WJ. eds. Slow transmissible diseases of the nervous system. Vol. 1. New York: Academic Press, 1979:253–70.
11. Johnson RT. Viral infections of the nervous system. New York: Raven Press, 1982:1–433.
12. Goudsmit J, Morrow CH, Asher DM, et al. Evidence for and against the transmissibility of Alzheimer disease. Neurology (NY) 1980; 30: 945–50.
13. Masters CL, Gajdusek DC, Gibbs CJ Jr. The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. Brain 1981; 104: 535–58.
14. Epstein CJ. Down's syndrome and Alzheimer's disease: implications and approaches. In: Katznian R, ed. Banbury report 15: biological aspects of Alzheimer's disease. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory, 1983:169–82.
15. Schechter R, Yen SHC, Terry RD. Fibrous astrocytes in senile dementia of the Alzheimer lype. J Neuropathol Exp Neurol 1981; 40: 95–101.
16. Landis DMD, Williams RS, Masters CL. Golgi and electronmicroscopic studies of spongifonn encephalopathy. Neurology (NY) 1981; 31: 538–49.
17. Terry RD, Davies P. DeTeresa R, Katzman R. Are both plaques and tangles required to make it Alzheimer's disease? J Neuropathol Exp Neurol 1982; 41: 364. abstract.
18. Markesbery WR, Ehmann WD, Hossain TIM, Alauddin M, Goodin DT. Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging. Ann Neurol 1981; 10: 511–6.
19. Coyle JT, Price DL, De Long MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983; 219: 1184–90.
20. Struble RG, Cork LC, Whitehouse PJ, Price DL. Cholinergic innervation in neuritic plaques. Science 1982; 216: 413–5.
21. Mountjoy CQ, Tomlinson BE, Gibson PH. Amyloid and senile plaques and cerebral blood vessels: a semi-quantiative investigation of a possible relationship. J Neurol Sci 1982; 57: 89–103.